The R&D technology of Huaxia Bio’s “Tongyansu” represents a paradigm shift in the anti-aging field, moving from traditional “chemical stimulation” to “physical regeneration + biological signaling.” Its core innovations lie in successfully translating medical aesthetic injection technologies into topical skincare formulations. The specific technological innovations are summarized in the following four dimensions:

1. Material Innovation: Nanoscaling of Medical Aesthetic “Regenerative Materials” (PCL)

• Traditional Limitation: Polycaprolactone (PCL), the core component of the famous “Girl Needle” (Ellansé), is a high-molecular-weight polymer. Traditionally, it could only be used via injection because its particle size was too large to penetrate the skin barrier, and improper processing would lead to granulomas or loss of activity.
• Tongyansu’s Innovation:
  • Nano-Microsphere Technology: Huaxia Bio utilized a specialized controlled polymerization process to break down PCL into nanometer-level microspheres with a diameter of approximately 100nm.
  • Activity Retention: This process ensures that while the particle size is reduced for transdermal absorption, the PCL retains its original biological activity to induce collagen regeneration.
  • Significance: This is the first time globally that an injection-grade regenerative material has been successfully transformed into a safe, effective, and absorbable topical serum ingredient, breaking the boundary between “life skincare” and “medical aesthetics.”

2. Delivery System Innovation: Microfluidic Jet Homogenization & Liposome Encapsulation

To ensure that large molecules like PCL and peptides reach the dermis, Tongyansu employs a dual-engine delivery system:

• Microfluidic Jet Homogenization:
  • Unlike traditional stirring or high-pressure homogenization which results in uneven particle sizes, this technology uses micro-channels to shear and crush particles at ultra-high speeds.
  • Result: It strictly controls the particle size distribution of the active ingredients to be uniform and below 500 Daltons (for small molecules) or around 100-200nm (for microspheres). This “golden size” allows direct penetration through the stratum corneum to the papillary dermis (approx. 120μm depth).
• Biomimetic Liposome Encapsulation:
  • Active ingredients are encapsulated in phospholipid bilayers that mimic human cell membranes.
  • Mechanism: This creates a “Trojan Horse” effect, allowing the skin to recognize and absorb the liposomes seamlessly, protecting the active ingredients from enzymatic degradation in the epidermis and ensuring they arrive intact at the target fibroblasts.

3. Mechanism Innovation: “Liquid Scaffold” and Smart Sustained-Release Technology

Tongyansu changes the way anti-aging ingredients work, shifting from “instant supplementation” to “long-term construction.”

• Liquid Scaffold Effect:
  • Once the PCL nanospheres enter the dermis, they do not dissolve immediately. Instead, they form an invisible, three-dimensional “liquid scaffold.”
  • This scaffold provides immediate physical support to fill fine lines and acts as a stimulus, inducing the body’s immune system to initiate a benign foreign body reaction. This signals fibroblasts to wrap around the microspheres and secrete large amounts of Type I and Type III collagen.
• 24-Hour Smart Sustained Release:
  • The liposome network releases active ingredients (PCL, peptides) continuously over 24 hours in response to skin temperature and metabolic changes.
  • Benefit: This avoids the irritation caused by high-concentration instant release and provides continuous signaling to cells, mimicking the long-lasting effect of medical aesthetic injections (lasting 3-6 months topically).

4. Formula Architecture Innovation: Multi-Dimensional Synergistic Matrix

Instead of relying on a single “star ingredient,” Tongyansu constructs a comprehensive anti-aging matrix through precise compounding:

• Dynamic Wrinkle Blocking: Combines Acetyl Hexapeptide-8 and Snake Venom-like Peptide to inhibit muscle contraction at the neuromuscular junction, addressing expression lines while collagen regeneration takes place.
• Volume Replenishment: Incorporates Japanese Patented Arnica Montana Flower Extract, which promotes the moderate proliferation of subcutaneous adipocytes. This addresses the loss of facial volume (e.g., sunken cheeks) caused by aging, a dimension often ignored by traditional serums.
• Anti-Inflammatory Safety Shield: Adds Tridecapeptide-1 and Soluble Collagen to inhibit inflammatory factors (like IL-6). This ensures that the “benign inflammation” induced by PCL for regeneration does not turn into harmful sensitivity, making the formula suitable even for sensitive skin.

Summary

The core technological innovation of Tongyansu lies in “Medical Aesthetic Topicalization.”

By using nanotechnology to downsize injection-grade PCL, microfluidics to ensure deep penetration, and sustained-release mechanisms to mimic long-term regenerative effects, it achieves a qualitative leap from superficial care to deep structural remodeling. This technology stack allows it to deliver results comparable to light medical aesthetic procedures through daily topical application.